MedPath

GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

Recruiting
Conditions
Gastric Content Aspiration
Registration Number
NCT05875636
Lead Sponsor
Medical University of South Carolina
Brief Summary

This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
260
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retained gastric foodFrom time of enrollment until the end of surgery, assessed up to 4 weeks

Incidence of clinically significant retained gastric food, defined as visible solid/particulate matter, or liquid volume \> 1.5cc/kg

Secondary Outcome Measures
NameTimeMethod
Incidence of pulmonary aspiration eventFrom the time surgery begins until the end of scheduled surgery, assessed up to 24 hours

Trial Locations

Locations (1)

Medical University of South Carolina

πŸ‡ΊπŸ‡Έ

Charleston, South Carolina, United States

Medical University of South Carolina
πŸ‡ΊπŸ‡ΈCharleston, South Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.